Select Country

Latest news

Bracco DIAGNOSTICS INC. and Amerinet announce GROUP PURCHASING agreement to INCLUDE LUMASON TM (sulfur hexafluoride lipid-type A microspheres) for injectable suspension for contrast echocardiography


Press release


The Centers for Medicare & Medicaid Approved Bracco Diagnostics Inc Ultrasound Contrast Agent, Lumason® (Sulfur Hexafluoride Lipid-Type A microspheres) for injectable Suspension, for Reimbursement, Under the Hospital Outpatient Prospective Payment System


Press release


Click here to learn about the TRUTH1 Study.
Reference 1. Maravilla KR, Smith MP, Vymazal J, Goyal M, Herman M, Baima JJ, Babbel R, Vaneckova M, Zižka J, Colosimo C, Urbańczyk-Zawadzka M, Mechl M, Bag AK, Bastianello S, Bueltmann E, Hirai T, Frattini T, Kirchin MA, Pirovano G. Are There Differences between Macrocyclic Gadolinium Contrast Agents for Brain Tumor Imaging? Results of a Multicenter Intraindividual Crossover Comparison of Gadobutrol with Gadoteridol (the TRUTH Study). AJNR Am J Neuroradiol. 2014 Oct 9. [Epub ahead of print]

Congress calendar

From November 29 to December 04, 2015
Chicago, IL


From December 07 to 09, 2015
Orange County, CA


Educational Events


Established to compare various clinical approaches for targeted diagnostic imaging.

Read more


Designed to help physicians stay abreast of the latest changes and applications in magnetic resonance.

Read more